Victoria Lane Randall, NP

Victoria Randall practices at Internal Medicine of the Twin Cities in Monroe, Louisiana.

Victoria Randall's NPI, 1396478830, was assigned on July 1, 2022. Victoria Randall holds Louisiana license 226274.

Victoria Randall's primary practice is Internal Medicine of the Twin Cities, at 2503 Broadmoor Blvd, Monroe, LA 71201 in Ouachita Parish. The practice phone is (318) 388-6050.

Victoria Randall's primary practice is Internal Medicine of the Twin Cities in Monroe, Louisiana. Victoria Randall is also affiliated with St. Francis Medical Center. The medical group on file is Internal Medicine Of The Twin Cities. Dmand AI also links Victoria Randall to 1 more hospital, 20 medical groups, 12 group practices and clinics and 3 skilled nursing facilities, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Victoria Randall practices, 17 sites in all. Vendor and product names are available with a free account.

Gerontology is Victoria Randall's primary specialty in the NPI Registry, under taxonomy code 363LG0600X. Dmand AI has Victoria Randall's licenses on file in 10 states: Louisiana, Alabama, Arkansas, Arizona, Colorado, Kentucky, New Mexico, Nevada, Tennessee and Texas.

CMS counts 264 Medicare patients who saw Victoria Randall in 2024. The largest group is 75 to 84, with 117 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 40% are also on Medicaid. Their average risk score is 2.57, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Victoria Randall's median patient age at 71, with 53% women.

In 2024, Victoria Randall wrote 1,583 Medicare Part D claims for 115 patients. 90% of them were for generic drugs.

Victoria Randall accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Victoria Randall as offering telehealth.

CMS Open Payments shows 3 general payments to Victoria Randall from 3 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $20.